# S&B Pharma LLC – FDA Inspection, Feb 5, 2019

Source: https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/636a1ff3-2f57-4421-b804-895b6916ba04
Source feed: FDA_Inspections

> FDA inspection 1078320 of S&B Pharma LLC, February 05, 2019. 8 citations under 21 CFR parts 211 and 314. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1078320
- Company Name: S&B Pharma LLC
- Inspection Date: 2019-02-05
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 8

## Related Documents

- FDA Inspection 1172319 - 2022-06-17
- FDA Inspection 1121238 - 2020-02-06
- [FDA Inspection 1047928 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/sb-pharma-llc/9d542333-9374-409a-93d6-381f4b1aa795)
- FDA Inspection 1031001 - 2017-10-27
- FDA Inspection 915801 - 2015-02-26

## Related Officers

- [Bei Y. He](https://www.keypedia.com/people/bei-y-he/6ee057b7-9558-4f4c-b312-9a63821699c2)
- [FDA Associated Person](https://www.keypedia.com/people/michele-perry-williams/80741e95-8df3-41c9-b9b8-499fcb97921d)

Company: https://www.keypedia.com/companies/sb-pharma-llc/232b2ea9-4ea7-41e2-aed7-7b885ca80003

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79